Connected eClinical Solutions: Why AI/ML Matters for Modern Clinical Trials — SCDM 2026

November 16, 2026

Clinical trials have become increasingly complex. Sponsors and contract research organizations (CROs) must coordinate clinical data, study sites, monitoring activities, essential documents, quality processes, and patient-facing technologies across multiple systems and stakeholders.

Although digital transformation has helped modernize clinical research, fragmented technology environments can still make it difficult to turn information into actionable insights.

Artificial intelligence (AI) and machine learning (ML) are creating new opportunities to address this challenge. However, their effectiveness depends on more than sophisticated algorithms. They need reliable data, connected workflows, appropriate governance, and a clear understanding of the clinical processes they are intended to support.

This is where connected eClinical solutions become important.

As the clinical data management community reflects on emerging technologies around SCDM 2026, the conversation is shifting from individual software capabilities toward a more integrated approach to clinical research. The question is no longer simply how to digitize individual processes, but how to connect data and workflows so teams can make better-informed decisions.

At Octalsoft, our approach centers on bringing clinical, operational, and quality capabilities together in a unified eClinical ecosystem, creating a foundation for more coordinated trial management and the responsible adoption of AI/ML.

What Are Connected eClinical Solutions?

Connected eClinical solutions are digital systems that support clinical research activities and enable information to move between relevant workflows.

These systems can include Electronic Data Capture (EDC), Clinical Trial Management Systems (CTMS), Electronic Trial Master Files (eTMF), Interactive Web Response Systems (IWRS/RTSM), electronic clinical outcome assessment solutions (eCOA), electronic patient-reported outcomes (ePRO), Remote Source Data Verification (rSDV), and Quality Management Systems (QMS).

Each system serves a distinct purpose.

EDC supports electronic clinical data collection and management. CTMS helps coordinate study operations and site activities. eTMF supports the management of essential trial documentation. IWRS/RTSM supports functions such as randomization and trial supply management, depending on the implementation. QMS supports the management of quality processes and associated records.

When these capabilities are connected appropriately, organizations can reduce information silos, improve visibility across workflows, and make relevant data more accessible to authorized stakeholders.

The result is a stronger operational foundation for managing clinical trials—and for exploring where AI/ML can add practical value.

Why AI/ML Needs Connected Clinical Data

AI and ML can identify patterns, classify information, generate summaries, and support predictions when the underlying data and use case are suitable.

But clinical research data is rarely meaningful in isolation.

A discrepancy in an EDC record may require investigation by a data manager. A recurring issue across sites may warrant operational review. A documentation gap may need attention from a quality or regulatory team.

Understanding these situations often requires information from more than one workflow.

Connected eClinical solutions can help provide that context, subject to data availability, system integration, access permissions, and appropriate governance.

This relationship can be understood through three elements:

Connected data: Relevant information is available across clinical, operational, and quality workflows.

Intelligent analysis: AI/ML can help identify patterns, potential anomalies, and areas that may require attention.

Human-led decisions: Qualified professionals assess the findings, consider the clinical context, and determine the appropriate response.

AI does not automatically make disconnected data reliable or eliminate the need for clinical expertise. Instead, a well-designed connected environment can provide a stronger foundation for useful and responsible AI applications.

Five Ways Connected eClinical Solutions and AI/ML Can Improve Clinical Trials

1. Better Clinical Data Quality and Review

Clinical data quality is essential to the reliability of trial results. Missing information, inconsistent entries, unexpected values, and unresolved discrepancies can create additional work for clinical data management teams.

EDC platforms support data collection, predefined validation checks, and query management. AI/ML techniques can potentially complement these controls by identifying unusual patterns or highlighting records that deserve closer review.

For example, repeated discrepancies in a particular field or an unexpected pattern across records may warrant investigation. Intelligent analysis can help prioritize such observations, while data managers determine whether they represent genuine issues or legitimate variations.

Connected workflows can also help teams understand whether an issue requires follow-up beyond the data capture system.

The objective is to make data review more targeted without replacing established validation procedures or professional judgment.

2. More Focused Risk-Based Quality Management

Risk-based quality management (RBQM) encourages clinical research organizations to focus oversight on factors that matter most to participant safety and the reliability of trial results.

AI/ML can potentially support RBQM by examining relevant clinical and operational information for patterns that may indicate emerging risks.

When connected data is available, teams may be better positioned to investigate relationships between data quality trends, site activities, and other relevant study indicators.

These insights can inform review priorities, but they must be evaluated against established risk criteria and study-specific requirements.

Octalsoft's eClinical ecosystem brings together capabilities relevant to clinical data management, trial operations, and quality workflows. This broader context can support organizations as they evaluate how intelligent analysis might complement existing risk-based processes.

3. Improved Operational Visibility Through CTMS

Clinical trial execution involves managing study milestones, site activities, monitoring, and outstanding operational tasks.

A CTMS helps centralize and coordinate many of these activities. When relevant operational information is connected with other clinical workflows, stakeholders can gain a clearer understanding of study progress and potential bottlenecks.

AI-assisted analysis may help summarize operational information, highlight recurring delays, and prioritize issues for review.

For instance, a pattern of unresolved data queries combined with delayed site follow-up may warrant investigation by the study team. Whether such an insight is available depends on the data accessible to the systems and the integration in place.

The value of connected technology is that it can help stakeholders investigate issues across workflows rather than relying exclusively on isolated reports.

4. Stronger Documentation and Quality Workflows

Clinical trials require comprehensive documentation and controlled processes to demonstrate that activities have been performed appropriately.

eTMF and QMS capabilities support different but complementary needs: managing essential trial documentation and managing quality processes, respectively.

Connected workflows can help teams improve access to relevant records and coordinate activities across functions.

AI-assisted document classification, information extraction, summarization, and exception identification may offer additional opportunities to reduce repetitive administrative work. These applications require suitable validation, document controls, access restrictions, and human review.

AI-generated summaries or classifications should not be treated as substitutes for required reviews or verified records.

The goal is to help quality and clinical operations professionals work more efficiently while maintaining the traceability and accountability expected in regulated research.

5. More Informed Decisions Across the Trial Lifecycle

Clinical trials involve decisions at multiple stages, from study startup and site activation to patient enrollment, ongoing monitoring, data cleaning, and closeout.

When information is distributed across disconnected systems, teams may spend valuable time collecting reports and reconciling data before they can evaluate a situation.

Connected eClinical solutions can help make relevant information more accessible to authorized stakeholders.

AI/ML can then potentially assist with pattern recognition, information summarization, and decision support within defined use cases.

For example, a study team might use consolidated information to identify outstanding tasks, investigate recurring issues, or understand where additional attention is required.

The final decision remains with the appropriate professional. AI should support clinical and operational judgment, not make consequential decisions without suitable oversight.

How Octalsoft Supports a Connected eClinical Ecosystem

Octalsoft provides an integrated portfolio of eClinical solutions designed to support clinical research organizations across data capture, study operations, documentation, and quality management.

Our portfolio includes:

  • EDC: Electronic clinical data capture, validation, and data management workflows.
  • CTMS: Clinical trial operations and study coordination.
  • eTMF: Essential trial document management.
  • IWRS/RTSM: Randomization and trial supply management workflows.
  • eCOA/ePRO: Digital approaches to capturing clinical outcomes and patient-reported information.
  • rSDV: Support for remote source data verification workflows.
  • QMS: Quality management processes and associated documentation.

These solutions address interconnected requirements across the clinical trial lifecycle.

Our unified-platform approach is designed to help organizations reduce the operational friction associated with fragmented systems and support more coordinated clinical workflows.

AI/ML adds another dimension to this evolution. When implemented for appropriate use cases, intelligent capabilities can help teams identify patterns, prioritize review activities, and access relevant information more effectively.

For Octalsoft, the opportunity is to bring intelligent technology closer to the workflows where it can support practical clinical research needs.

Specific AI functionality, integrations, and automation capabilities should always be evaluated against the relevant product configuration and intended use.

Responsible AI in Clinical Research: Governance Comes First

The adoption of AI/ML in clinical trials must be accompanied by appropriate safeguards.

Clinical research depends on reliable records, controlled processes, participant confidentiality, and accountability. Introducing intelligent technology should strengthen these foundations rather than create uncertainty about how data is processed or decisions are made.

Organizations evaluating AI-enabled eClinical solutions should consider the following areas.

Data integrity and traceability: Ensure that relevant records and changes remain appropriately documented and controlled.

Privacy and security: Protect sensitive clinical information through suitable permissions, access controls, and security measures.

Validation and verification: Assess systems and AI-enabled functions according to their intended use and applicable requirements.

Transparency and explainability: Provide sufficient context for users to assess important findings and recommendations.

Human oversight: Establish clear responsibilities for reviewing outputs, resolving exceptions, and approving consequential actions.

Ongoing monitoring: Evaluate model performance and reassess suitability as data, workflows, and operating conditions change.

The appropriate controls depend on the application, its risk, and the regulatory context. AI-generated findings should not automatically be treated as verified clinical facts.

A connected technology environment can help organizations establish more coordinated workflows, but governance remains an essential responsibility.

SCDM 2026: Moving From Digital Systems to Intelligent Clinical Workflows

The Society for Clinical Data Management provides a forum for clinical data professionals to discuss evolving practices, emerging technologies, and the future of the discipline.

The growing interest in AI/ML raises important questions for sponsors, CROs, and clinical technology providers.

How can AI complement existing data management processes? What information is needed to generate useful insights? How can organizations assess the reliability of AI-generated outputs? And how can intelligent systems operate within regulated workflows while maintaining appropriate human oversight?

These questions point toward a broader industry priority: integrating technology, data, and processes in ways that support measurable improvements.

For organizations evaluating eClinical platforms, several considerations are particularly important:

  • The ability to connect relevant clinical and operational workflows.
  • Data quality and the availability of appropriate information.
  • Integration with existing systems and processes.
  • Security, governance, and regulatory suitability.
  • Clear objectives for evaluating the value of AI/ML applications.

The strongest approach is to begin with a defined clinical or operational challenge, identify a suitable use case, and assess its performance using meaningful measures.

AI should be adopted because it addresses a real need—not simply because it is available.

Conclusion: Connected Data Is the Foundation for Smarter Clinical Trials

The future of clinical research will depend on more than digitizing individual activities. It will require technology that helps organizations connect information, coordinate workflows, and make better-informed decisions.

AI/ML can contribute through data quality review, anomaly detection, risk-based oversight, workflow assistance, and decision support. But these capabilities depend on suitable data, reliable systems, appropriate governance, and human expertise.

Connected eClinical solutions provide an important foundation for bringing these elements together.

At Octalsoft, our integrated eClinical portfolio supports key clinical research workflows across data capture, study operations, documentation, and quality management. We believe that combining this connected foundation with responsible AI/ML adoption can help organizations pursue more efficient, coordinated, and data-informed clinical trial management.

As the clinical data management community continues to explore the possibilities of intelligent technology, one principle remains clear: better-connected data can create better opportunities for informed decisions.

Explore our eClinical solutions and discuss your clinical research technology requirements with our team.

Request a demo: https://www.octalsoft.com/request-a-demo/

Octalsoft. One Platform. Complete Control. Intelligent Solutions.

Amol Nemade

Amol Nemade

This piece was co-authored by Nishan Raj, Senior Content Writer at Octalsoft.

Amol Nemade

This piece was co-authored by Nishan Raj, Senior Content Writer at Octalsoft.
Amol Nemade is a results-driven sales leader with over a decade of experience driving commercial success in the pharmaceutical and clinical research industries. As Sales Director at Octalsoft, he leverages his deep industry expertise to develop data-driven sales strategies, manage key global accounts, and drive clinical trial innovation. With a strong foundation in sales execution, relationship management, and digital transformation, Amol continues to drive business growth and innovation in the evolving clinical research landscape.